MedPath

Flanders Medical Research Program

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries

Phase 2
Completed
Conditions
Peripheral Arterial Disease
Interventions
Device: Self-expandable drug eluting stent
First Posted Date
2012-06-28
Last Posted Date
2015-03-09
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
70
Registration Number
NCT01630070
Locations
🇧🇪

UZA, Edegem, Antwerp, Belgium

🇧🇪

RZ Heilig-Hartziekenhuis, Tienen, Antwerp, Belgium

🇧🇪

Imelda Hospital, Bonheiden, Antwerp, Belgium

and more 2 locations

PREVENT: Promus BTK

Phase 2
Completed
Conditions
Peripheral Arterial Disease
Interventions
Device: Everolimus-Eluting Stent (PROMUS ELEMENT)
First Posted Date
2011-12-26
Last Posted Date
2016-08-11
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
70
Registration Number
NCT01500070
Locations
🇩🇪

Herzzentrum Bad-Krözingen, Bad-Krözingen, Land Baden-Württemberg, Germany

🇳🇿

Auckland City Hospital, Auckland City, Auckland, New Zealand

🇩🇪

Herzzentrum Leipzig, Leipzig, Freistaat Sachsen, Germany

and more 5 locations

Drug Eluting Stents In The Critically Ischemic Lower Leg 2

Phase 2
Completed
Conditions
Peripheral Arterial Disease
Interventions
Device: stent
First Posted Date
2011-09-28
Last Posted Date
2015-03-09
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
60
Registration Number
NCT01442636
Locations
🇦🇺

Prince of Wales Private Hospital, Randwick, New South Wales, Australia

🇩🇪

Herz-zentrum Bad Krozingen, Bad Krozingen, Germany

🇩🇪

Herzzentrum, Leipzig, Germany

and more 3 locations

4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease

Phase 4
Completed
Conditions
Peripheral Vascular Disease
Claudication
Interventions
Device: 4F portfolio products from Biotronik
First Posted Date
2011-08-10
Last Posted Date
2013-10-01
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
120
Registration Number
NCT01413139
Locations
🇧🇪

Imelda hospital, Bonheiden, Antwerpen, Belgium

🇧🇪

Universitair ziekenhuis antwerpen, Edegem, Antwerpen, Belgium

🇩🇪

St Fransiskus hospital, Münster, Germany

and more 2 locations

DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions

Phase 4
Completed
Conditions
Peripheral Arterial Disease
Interventions
Device: stent placement
First Posted Date
2011-08-09
Last Posted Date
2013-10-01
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
60
Registration Number
NCT01412463
Locations
🇧🇪

University Hospital Antwerp, Edegem, Antwerp, Belgium

🇧🇪

Imelda Hospital, Bonheiden, Antwerp, Belgium

🇧🇪

A.Z. Sint-Blasius, Dendermonde, East-Flanders, Belgium

Efficacity Study With the Protégé EverFlex Stent in Popliteal Lesions

Phase 4
Completed
Conditions
Peripheral Arterial Disease
Interventions
Device: nitinol stent
First Posted Date
2011-08-09
Last Posted Date
2013-10-01
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
60
Registration Number
NCT01412450
Locations
🇧🇪

Imeldaziekenhuis, Bonheiden, Antwerp, Belgium

🇧🇪

University Hospital Antwerp, Edegem, Antwerp, Belgium

🇧🇪

A.Z. Sint-Blasius, Dendermonde, East-Flanders, Belgium

and more 1 locations

GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis

Phase 4
Completed
Conditions
Peripheral Vascular Disease
Interventions
Device: GORE VIABAHN® Endoprosthesis
Device: Plain old balloon angioplasty
First Posted Date
2010-04-22
Last Posted Date
2014-09-03
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
100
Registration Number
NCT01108861
Locations
🇧🇪

AZ Sint-Blasius, Dendermonde, Belgium

🇩🇪

Herzzentrum, Leipzig, Germany

🇧🇪

Universitair ziekenhuis antwerpen, Edegem, Belgium

and more 3 locations

Misago Iliac Study

Completed
Conditions
Vascular Lesions
Interventions
Device: Misago (stent placement)
First Posted Date
2009-11-19
Last Posted Date
2014-08-06
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
100
Registration Number
NCT01016275
Locations
🇧🇪

Imelda Hospital, Bonheiden, Antwerp, Belgium

🇧🇪

UZ Gent, Gent, East-Flanders, Belgium

🇧🇪

AZ Sint-Blasius, Dendermonde, East-Flanders, Belgium

and more 2 locations

Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions

Phase 4
Completed
Conditions
Peripheral Vascular Disease
Intermittent Claudication
Critical Limb Ischemia
Interventions
Device: iliac stenting
First Posted Date
2008-10-02
Last Posted Date
2013-01-25
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
325
Registration Number
NCT00764777
Locations
🇧🇪

AZ Sint-Blasius, Dendermonde, Belgium

🇧🇪

University Hospital, Ghent, Belgium

🇧🇪

Imelda Hospital, Bonheiden, Belgium

and more 2 locations

EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study

Phase 2
Terminated
Conditions
Peripheral Arterial Occlusive Disease
Interventions
Device: Spectranetics Turbo elite™ excimer laser catheter
First Posted Date
2008-07-21
Last Posted Date
2015-03-09
Lead Sponsor
Flanders Medical Research Program
Target Recruit Count
14
Registration Number
NCT00718991
Locations
🇧🇪

AZ St-Blasius, Dendermonde, Belgium

🇧🇪

Imelda Hospital, Bonheiden, Belgium

© Copyright 2025. All Rights Reserved by MedPath